fluorine has been researched along with Alzheimer Disease in 24 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 8 (33.33) | 18.7374 |
1990's | 2 (8.33) | 18.2507 |
2000's | 4 (16.67) | 29.6817 |
2010's | 7 (29.17) | 24.3611 |
2020's | 3 (12.50) | 2.80 |
Authors | Studies |
---|---|
Dai, Y; Fang, T; Jiang, T; Qiao, J; Xu, Y | 1 |
Burgos, CF; Castillo, C; F de la Torre, A; Fuentealba, J; Jiménez, CA; López, JJ; Sáez-Orellana, F; Sánchez, Y | 1 |
Dabur, M; Loureiro, JA; Pereira, MC | 1 |
Hirao, K; Ibrahim, NF; Kato, T; Morikawa, S; Shirai, N; Sogabe, T; Taguchi, H; Tooyama, I; Yanagisawa, D | 1 |
Banner, DW; Bergadano, A; David-Pierson, P; Fischer, H; Guba, W; Hilpert, H; Hochstrasser, R; Humm, R; Jacobsen, H; Krummenacher, D; Kuglstatter, A; Mauser, H; Mayweg, AV; Muser, T; Narquizian, R; Ozmen, L; Pinard, E; Polara, A; Rogers-Evans, M; Schnider, C; Woltering, TJ; Wostl, W | 1 |
de Backer, M; de Jongh, S; Jiskoot, W; Kapoerchan, VV; Metaxas, A; Nabuurs, RJ; Overhand, M; Overkleeft, HS; van Buchem, MA; van der Weerd, L; Welling, MM; Windhorst, AD | 1 |
Coelho, MA; Gomes, B; Loureiro, JA; Pereira, Mdo C | 1 |
Hirao, K; Ibrahim, NF; Inubushi, T; Kato, T; Morikawa, S; Shirai, N; Sogabe, T; Taguchi, H; Tooyama, I; Yanagisawa, D | 1 |
Forsback, S; Haaparanta-Solin, M; Kaasalainen, M; La Ferla, B; Lopez-Picon, F; Masserini, M; Nicotra, F; Re, F; Rinne, JO; Rokka, J; Salonen, J; Snellman, A; Solin, O; Zona, C | 1 |
Khosravan, A; Marani, S; Sadeghi Googheri, MS | 1 |
Aksinenko, AY; Makhaeva, GF; Richardson, RJ; Serebryakova, OG; Sokolov, VB | 1 |
Abid, M; Foster, M; Hailemichael, S; Sood, A; Török, B; Török, M | 1 |
Beswick, P; Charrier, N; Clarke, B; Demont, E; Dingwall, C; Dunsdon, R; Faller, A; Gleave, R; Hawkins, J; Hussain, I; Johnson, CN; MacPherson, D; Maile, G; Matico, R; Milner, P; Mosley, J; Naylor, A; O'Brien, A; Redshaw, S; Riddell, D; Rowland, P; Skidmore, J; Smith, KJ; Soleil, V; Stanway, S; Stemp, G; Stuart, A; Sweitzer, S; Theobald, P; Vesey, D; Walter, DS; Ward, J; Wayne, G | 1 |
Creasey, H; Cutler, NR; Duara, R; Grady, CL; Haxby, JV; Rapoport, SI; Schapiro, MB | 1 |
Kameyama, M; Kuhl, DE; Metter, EJ; Phelps, ME; Riege, WH | 1 |
Brant-Zawadzki, M; Budinger, TF; Friedland, RP; Jagust, WJ | 1 |
Budinger, TF; Derenzo, SE; Friedland, RP; Ganz, E; Huesman, RH; Koss, B; Mathis, CA; Ober, BA; Yano, Y | 1 |
Benson, DF; Cummings, JL; Hawkins, RA; Kuhl, DE; Phelps, ME; Tsai, SY | 1 |
Agwani, N; Forbes, WF | 1 |
Williams, DR | 1 |
Majamaa, K; Mannermaa, RM; Oikarinen, J; Tarkka, T; Yli-Mäyry, N | 1 |
Ando, K; Yokoi, F | 1 |
Benson, DF | 1 |
Friedland, RP; Jagust, WJ; Koss, E; Ober, BA | 1 |
5 review(s) available for fluorine and Alzheimer Disease
Article | Year |
---|---|
Fluorinated Molecules and Nanotechnology: Future 'Avengers' against the Alzheimer's Disease?
Topics: Alzheimer Disease; Amyloid beta-Peptides; Biomarkers; Drug Development; Drug Discovery; Fluorine; Humans; Molecular Targeted Therapy; Nanomedicine; Nanotechnology; Protein Aggregates; Structure-Activity Relationship; Theranostic Nanomedicine | 2020 |
The Potential Effect of Fluorinated Compounds in the Treatment of Alzheimer's Disease.
Topics: Alzheimer Disease; Amyloid beta-Peptides; Fluorine; Humans; Molecular Conformation; Neuroprotective Agents | 2015 |
Amyloid imaging using fluorine-19 magnetic resonance imaging ((19)F-MRI).
Topics: Alzheimer Disease; Amyloidosis; Animals; Fluorine; Humans; Magnetic Resonance Imaging; Multimodal Imaging; Plaque, Amyloid; Positron-Emission Tomography; Styrenes | 2016 |
Chemical speciation applied to bio-inorganic chemistry.
Topics: Aluminum; Alzheimer Disease; Anti-Ulcer Agents; Bismuth; Calcium; Chemistry, Bioinorganic; Common Cold; Dentifrices; Fluorine; Humans; Tin; Ulcer; Zinc | 2000 |
[PET imaging of dementia].
Topics: Adolescent; Adult; Aged; Alzheimer Disease; Brain; Carbon Radioisotopes; Child; Dementia; Fluorine; Humans; Huntington Disease; Middle Aged; Oxygen Radioisotopes; Radioisotopes; Tomography, Emission-Computed | 1985 |
19 other study(ies) available for fluorine and Alzheimer Disease
Article | Year |
---|---|
Multi-fluorine labeled indanone derivatives as potential MRI imaging probes for β-Amyloid plaques.
Topics: Alzheimer Disease; Amyloid beta-Peptides; Animals; Brain; Fluorine; Humans; Indans; Magnetic Resonance Imaging; Mice; Mice, Transgenic; Plaque, Amyloid; Tissue Distribution | 2023 |
New Benzodihydrofuran Derivatives Alter the Amyloid β Peptide Aggregation: Strategies To Develop New Anti-Alzheimer Drugs.
Topics: Aged; Alzheimer Disease; Amyloid beta-Peptides; Chalcone; Chalcones; Fluorine; Humans | 2023 |
Fluorine-19 magnetic resonance imaging probe for the detection of tau pathology in female rTg4510 mice.
Topics: Aged; Alzheimer Disease; Animals; Benzoxazoles; Brain; Butadienes; Disease Models, Animal; Female; Fluorine; Fluorine-19 Magnetic Resonance Imaging; Humans; Male; Mice; Mice, Transgenic; Neurofibrillary Tangles; tau Proteins; Tauopathies | 2018 |
β-Secretase (BACE1) inhibitors with high in vivo efficacy suitable for clinical evaluation in Alzheimer's disease.
Topics: Alzheimer Disease; Amyloid Precursor Protein Secretases; Animals; Aspartic Acid Endopeptidases; Brain Chemistry; Enzyme Inhibitors; Female; Fluorine; Humans; Indicators and Reagents; Male; Mice; Mice, Inbred C57BL; Mice, Transgenic; Models, Molecular; Oxazines; Rats; Rats, Wistar; Structure-Activity Relationship; X-Ray Diffraction | 2013 |
Polyfluorinated bis-styrylbenzenes as amyloid-β plaque binding ligands.
Topics: Alzheimer Disease; Amyloid beta-Peptides; Animals; Benzene; Binding, Competitive; Brain; Contrast Media; Drug Design; Fluorescent Dyes; Fluorine; Humans; Ligands; Magnetic Resonance Spectroscopy; Mice; Mice, Transgenic; Protein Binding; Spectrometry, Fluorescence | 2014 |
(18)F-labeling syntheses and preclinical evaluation of functionalized nanoliposomes for Alzheimer's disease.
Topics: Alzheimer Disease; Animals; Autoradiography; Brain; Female; Fluorine; Fluorine Radioisotopes; Genes, Transgenic, Suicide; Liposomes; Male; Mice; Molecular Structure; Nanostructures; Positron-Emission Tomography; Radiopharmaceuticals; Technology, Pharmaceutical; Tissue Distribution | 2016 |
The effects of fluorine substitution on the chemical properties and inhibitory capacity of Donepezil anti-Alzheimer drug; density functional theory and molecular docking calculations.
Topics: Alzheimer Disease; Donepezil; Electrons; Fluorine; Humans; Hydrogen Bonding; Indans; Models, Molecular; Molecular Docking Simulation; Piperidines; Quantum Theory; Spectroscopy, Fourier Transform Infrared; Spectrum Analysis, Raman; Static Electricity | 2017 |
Synthesis of organophosphates with fluorine-containing leaving groups as serine esterase inhibitors with potential for Alzheimer disease therapeutics.
Topics: Acetylcholinesterase; Alzheimer Disease; Animals; Butyrylcholinesterase; Cholinesterase Inhibitors; Fluorine; Horses; Humans; Neuroprotective Agents; Organophosphates; Swine | 2009 |
Effect of chirality of small molecule organofluorine inhibitors of amyloid self-assembly on inhibitor potency.
Topics: Alzheimer Disease; Amyloid beta-Peptides; Fluorine; Humans; Microscopy, Atomic Force; Propionates; Spectrometry, Fluorescence; Stereoisomerism | 2009 |
BACE-1 inhibitors part 3: identification of hydroxy ethylamines (HEAs) with nanomolar potency in cells.
Topics: Alzheimer Disease; Amyloid beta-Protein Precursor; Animals; Asparagine; Aspartic Acid Endopeptidases; Combinatorial Chemistry Techniques; Crystallography, X-Ray; Disease Models, Animal; Ethylamines; Fluorine; Mice; Molecular Structure; Nanotechnology; Structure-Activity Relationship | 2008 |
NIH Conference. Brain imaging: aging and dementia.
Topics: Adult; Aged; Aging; Alzheimer Disease; Brain; Deoxyglucose; Down Syndrome; Female; Fluorine; Fluorodeoxyglucose F18; Glucose; Humans; Male; Mental Processes; Middle Aged; Radioisotopes; Tomography, Emission-Computed; Tomography, X-Ray Computed; Wechsler Scales | 1984 |
Cerebral metabolic relationships for selected brain regions in Alzheimer's, Huntington's, and Parkinson's diseases.
Topics: Aged; Alzheimer Disease; Cerebral Cortex; Deoxyglucose; Fluorine; Humans; Huntington Disease; Middle Aged; Parkinson Disease; Radioisotopes | 1984 |
The diagnosis of Alzheimer-type dementia. A preliminary comparison of positron emission tomography and proton magnetic resonance.
Topics: Alzheimer Disease; Deoxyglucose; Fluorine; Fluorodeoxyglucose F18; Humans; Magnetic Resonance Spectroscopy; Male; Middle Aged; Radioisotopes; Tomography, Emission-Computed; Tomography, X-Ray Computed | 1984 |
Regional cerebral metabolic alterations in dementia of the Alzheimer type: positron emission tomography with [18F]fluorodeoxyglucose.
Topics: Aged; Alzheimer Disease; Cerebral Cortex; Dementia; Deoxy Sugars; Deoxyglucose; Female; Fluorine; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Radioisotopes; Tomography, Emission-Computed | 1983 |
The fluorodeoxyglucose 18F scan in Alzheimer's disease and multi-infarct dementia.
Topics: Aged; Alzheimer Disease; Brain; Dementia; Deoxy Sugars; Deoxyglucose; Female; Fluorine; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Radiography; Radioisotopes; Tomography, Emission-Computed | 1983 |
A suggested mechanism for aluminum biotoxicity.
Topics: Aluminum; Alzheimer Disease; Dose-Response Relationship, Drug; Fluorine; Humans; Ontario; Silicon Dioxide; Water; Water Supply | 1994 |
Interference of AlF4- with nucleotide and DNA binding of rat histone H1 in vitro. Implications for the pathogenesis of Alzheimer's disease.
Topics: Aluminum; Aluminum Compounds; Alzheimer Disease; Animals; Binding Sites; DNA; Fluorides; Fluorine; Histones; Liver; Nucleotides; Rats | 1991 |
Neuroimaging and dementia.
Topics: Alzheimer Disease; Atrophy; Brain; Brain Neoplasms; Cerebral Angiography; Dementia; Deoxyglucose; Fluorine; Humans; Huntington Disease; Hydrocephalus; Magnetic Resonance Spectroscopy; Pneumoencephalography; Radioisotopes; Tomography, Emission-Computed; Tomography, X-Ray Computed | 1986 |
Differences in lateral hemispheric asymmetries of glucose utilization between early- and late-onset Alzheimer-type dementia.
Topics: Age Factors; Aged; Alzheimer Disease; Brain; Deoxyglucose; Dominance, Cerebral; Female; Fluorine; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Psychiatric Status Rating Scales; Radioisotopes; Tomography, Emission-Computed; Wechsler Scales | 1985 |